- Filed
- Apr 28, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 27, 2026 | 16.13M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 16.08M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 16.38M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $0 |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $10.9M |
| Capex | Q1 2026 · Mar 31, 2026 | $9.1M |
| Capex | Q1 2026 · Mar 31, 2025 | $32.7M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $500K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $1.5M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $360.5M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $345.5M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $36.5M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $30.7M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $813.8M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $825.3M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $836.6M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $854.6M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $200.4M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $216.2M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $756M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $763M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $522.1M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $526M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $1.57B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $1.59B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.80 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.38 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.80 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.38 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $20.6M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $28.9M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$12.8M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$6.3M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$10.4M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$4M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $361.2M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $341.5M |